Lobbying Activity Report

6049-43870

Organization: BGP Pharma ULC dba Viatris Canada
Did any other entity with a direct interest in the outcome of this lobbying activity work together for the purpose of performing this lobbying activity? Yes
Lobbying activity performed with and/or on behalf of the following other entities with a direct interest in the outcome of the lobbying activity that worked together for the purpose of performing this lobbying activity: Canadian Generic Pharmaceuticals Association
Associated registration: 11264-6049-2
Lobbying Activity date: 2025-05-23
Arranged a meeting: No
Posted date: 2025-07-09

In-house lobbyists who participated in the lobbying activity: Mark Holle
Senior Public Office Holders who were lobbied in this activity: Sue Bouma, Executive Director, Clinical Services & Evaluation
Pharmaceutical, Laboratory & Blood Services Division, Health

John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement Branch, Health

Tijana Fazlagic, Executive Director, Therapeutic Assessment&Access
PharmaCare Benefits Branch, Provincial Health Services Authority

Sarah Pugh, Executive Director
Integrated Health Services, Planning& Systems, Health

Ian Rongve, ADM
Pharmaceutical Laboratory & Blood Services Division, Health

Rebecca Watt, Director, Laboratory Services
Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Ongoing interactions related to increased and sustainable utilization of generic and brand medications and a predictable and viable business environment for prescription medicines.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Government Procurement, Health, Hospitals, Mental Health and Addictions
 
Lobbying Activity Report amended on: 2025-07-09 previous entry: 6049-43055
Reason for amendment: Amending the Activity Report to identify other identities attending the lobbying activity (CGPA).
 
Senior officer who filed this Lobbying Activity Report: Jeffrey Long
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Return to Registration for FCA Canada Inc.
Date Modified: